Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Molecular Biology

Background:

• Alpha 2-adrenoreceptors (AR) play crucial roles in various physiological processes.
• Existing alpha 2-AR antagonists lack subtype selectivity, necessitating the development of novel agonists.
• Understanding ligand-receptor interactions is key to designing selective modulators.

Purpose of the Study:

• To transform known alpha 2-AR antagonists into novel agonists with improved subtype selectivity.
• To investigate the structure-activity relationships governing alpha 2-AR activation.
• To identify compounds with high efficacy and specific alpha 2C-AR subtype activation.

Main Methods:

• Chemical modification of antagonist lead structures by introducing phenyl, bioisosteric, or aliphatic moieties.
• Synthesis of novel compounds based on the modified lead structure.
• Functional assays to evaluate the agonist properties and subtype selectivity of the synthesized compounds.

Main Results:

• Novel compounds were synthesized and their functional properties evaluated.
• Compounds 7, 12, and 13 demonstrated high efficacy as alpha 2-AR agonists.
• Compounds 11 and 15 exhibited significant alpha 2C-AR subtype selective activation.
• Favorable ligand-receptor interactions within the binding site cavity were identified as crucial for activation.

Conclusions:

• The introduction of specific pendant groups to the antagonist scaffold successfully generated potent alpha 2-AR agonists.
• The study identified key interactions between ligand pendant groups and the transmembrane domain 6 aromatic cluster, driving alpha 2-AR activation.
• These findings provide a foundation for developing subtype-selective alpha 2-AR modulators for therapeutic applications.